Patent application number | Description | Published |
20080263288 | System and Method for Probing Hypervisor Tasks in an Asynchronous Environment - A system, method, and computer-usable medium for probing hypervisor tasks in an asynchronous environment. According to an embodiment of the invention, the partition firmware sends a request for data to the hypervisor. When the hypervisor receives the request for data, the hypervisor returns a taskID that identifies the task allocated to handle the request. Partition firmware records the taskID and a timestamp, which indicates the time in which the hypervisor received the request. A timer is set to measure the amount of time elapsed since the task ID was received by a requesting partition firmware. If the hypervisor has not provided the partition firmware with the requested data after a predetermined time period measured by the timer has elapsed, the partition firmware inquires about the status of the task associated with the taskID. If the task is still running, the partition firmware returns control of the partition to the operating system. | 10-23-2008 |
20130013759 | MANAGING INVENTORY DATA FOR COMPONENTS OF A SERVER SYSTEM - Techniques are disclosed for managing inventory data for components of a server system. In one embodiment, a global management controller is provided, that is operatively connected to a plurality of local management controllers. Each local management controller is configured to manage a subset of the components of the server system. Each local management controller is also configured to generate, for each component, a checksum based on vital product data (VPD) of the component. Each local management controller is also configured to compute a composite checksum based on the checksums generated for the components in the subset. The global management controller is configured to maintain a global view of the VPD in the computer system, based on the checksums and/or composite checksums. | 01-10-2013 |
20130067134 | PSEUDO MULTI-MASTER I2C OPERATION IN A BLADE SERVER CHASSIS - A system and method are directed towards a pseudo multi-master operation on a serial bus. The pseudo multi-master operation allows multiple devices without standard multi-master functionality to operate on the serial bus as masters. In a disclosed example, the serial bus is an Inter-Integrated Circuit (I2C) bus, which is isolated when an adapter card requires access to the I2C bus, such as to update vital product data (VPD) to a memory device, and to cache the updated VPD to a chassis management module. | 03-14-2013 |
20130097314 | MANAGING INVENTORY DATA FOR COMPONENTS OF A SERVER SYSTEM - Techniques are disclosed for managing inventory data for components of a server system. In one embodiment, a global management controller is provided, that is operatively connected to a plurality of local management controllers. Each local management controller is configured to manage a subset of the components of the server system. Each local management controller is also configured to generate, for each component, a checksum based on vital product data (VPD) of the component. Each local management controller is also configured to compute a composite checksum based on the checksums generated for the components in the subset. The global management controller is configured to maintain a global view of the VPD in the computer system, based on the checksums and/or composite checksums. | 04-18-2013 |
Patent application number | Description | Published |
20100247517 | USE OF MNK INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE - The present invention relates to the use of modulators of the kinase activity of Mnk1 and/or Mnk2 the diagnosis, alleviation, treatment and/or prevention of a tauopathy. Particularly, the present invention relates to the use of a modulator of Mnk1 and/or Mnk2 kinase for the diagnosis, alleviation, treatment and/or prevention of Alzheimer's disease. Preferably, the compounds are condensed pyrimidines. | 09-30-2010 |
20110003741 | NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE - The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability. | 01-06-2011 |
20110212102 | HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 09-01-2011 |
20110212103 | THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-01-2011 |
20110217311 | CYCLOALKYL CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyrimidine compounds of general formula | 09-08-2011 |
20110277045 | METHODS FOR INCREASING BETA CELL MASS COMPRISING ADMINISTERING A RA770 POLYPEPTIDE - The present invention discloses polynucleotides which identify and encode DP119, DP444, DP810, DP685, WE474, DP160, RA977, or RA770 as well as novel functions for these proteins of the inventions. The invention provides for compositions for disorders associated with the expression of the proteins of the invention, such as for the treatment, alleviation and/or prevention of pancreatic dysfunction (for example diabetes, hyperglycemia, and impaired glucose tolerance), and related disorders, and other disease and disorders. | 11-10-2011 |
20120128686 | THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 05-24-2012 |
20130065914 | HALOGEN OR CYANO SUBSTITUTED THIENO [2,3-D]PYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS - The present invention relates to novel thienopyhmidine compounds of general formula (I), pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof. | 03-14-2013 |
20130231283 | NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE - The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability. | 09-05-2013 |
Patent application number | Description | Published |
20080207594 | Use of Gsk-3 Inhibitors for Preventing and Treating Pancreatic Autoimmune Disorders - This invention relates to the use of Pax4 stimulating compounds, e.g. Glycogen synthase kinase-3 (GSK-3) inhibitors, particularly in combination with immunomodulating agents, in the prevention, and/or treatment of pancreatic autoimmune disorders, e.g. type I diabetes or LADA. More particularly, this invention relates to the use of compounds selected from paullones, indirubines, substituted ureas, maleimide derivatives and pyrimidine thiones. Further, the present invention relates to a method of identifying and/or characterizing pancreatic beta-cell mitogens by using cells expressing a pancreatic gene or a gene whose function is controlled by a pancreatic gene, particularly the Pax4 gene, and which are transfected with a reporter gene. | 08-28-2008 |
20080241106 | Method for Preventing and Treating Diabetes Using Neurturin - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product. | 10-02-2008 |
20090258829 | NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN - The present invention relates to formulations with protein growth factors, particularly neurturin as active ingredients and low molecular weight polyanionic excipients having increased bioavailability. | 10-15-2009 |
20110256113 | METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product. | 10-20-2011 |
20130053313 | NEW FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN - The present invention relates to formulations with protein growth factors, particularly neurturin as active ingredients and low molecular weight polyanionic excipients having increased bioavailability. | 02-28-2013 |
20130150293 | METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product. | 06-13-2013 |
20140162948 | FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN - The present invention relates to formulations with protein growth factors, particularly neurturin as active ingredients and low molecular weight polyanionic excipients having increased bioavailability. | 06-12-2014 |
20140274897 | METHOD FOR PREVENTING AND TREATING DIABETES USING NEURTURIN - The present invention relates generally to methods for preventing and/or treating pancreatic disorders, particularly those related to diabetes, by administering a neurturin protein product. | 09-18-2014 |
20160060317 | NOVEL NEURTURIN CONJUGATES FOR PHARMACEUTICAL USE - The present invention relates to neurturin protein products conjugated to polyols and to pharmaceutical compositions comprising neurturin conjugates as active ingredients, preferably PEGylated neurturin conjugates or variants thereof, having increased bioavailability. | 03-03-2016 |
Patent application number | Description | Published |
20080256717 | Inflatable Two Chamber Bed with Raised Headboard - An inflatable mattress. The inflatable mattress comprises a support system having upper and lower inflatable support chambers arranged in a substantially vertical manner and an inflatable headboard chamber arranged in a substantially perpendicular manner to the upper and lower inflatable chambers. Each inflatable support chamber comprises a top layer and a bottom layer. The inflatable mattress may further comprise an inflatable reinforcing chamber disposed between the upper and lower inflatable support chambers and attached to the lower inflatable support chamber. | 10-23-2008 |
20080286117 | Pump with automatic deactivation mechanism - An automatic deactivation mechanism is configured for an air bladder pump having a casing and a motor located therein to pump air into an air bladder from the atmosphere and through an air valve connected through the casing. The automatic deactivation mechanism includes a housing positioned within the casing and has defined therethrough a first aperture in fluid communication with the atmosphere through the casing and a second aperture in fluid communication with the air bladder through the casing. Included within the housing are at least two switches and a diaphragm positioned between the switches. The housing is sealed so that when a threshold pressure is reached therein, at least one switch is triggered by deflection of the diaphragm to automatically deactivate the pump by de-energizing the motor. | 11-20-2008 |
20080286124 | PUMP FOR INFLATABLE OBJECTS WITH INTEGRATED LIGHT SOURCE - A pump for inflatable objects having a housing including an air inlet and an air outlet, a motor positioned within said housing, an impeller positioned within the housing for moving air, a light source defined on an exterior of the housing; and a reflector disposed on the housing proximate the light source. | 11-20-2008 |
20090085393 | Inflatable Chair With Cushion Top - Disclosed herein is an inflatable chair having at least three sections. The inflatable chair has a lower inflatable support chamber that has a top and bottom layer. The inflatable chair also has an upper cushioning portion and a stabilizing member. The upper cushioning portion and the stabilizing member are in fluid communication with the lower inflatable support chamber. The inflatable chair is made of a high elastic PVC material. | 04-02-2009 |
20110318194 | PUMP WITH AUTOMATIC DEACTIVATION MECHANISM - An automatic deactivation mechanism is configured for an air bladder pump having a casing and a motor located therein to pump air into an air bladder from the atmosphere and through an air valve connected through the casing. The automatic deactivation mechanism includes a housing positioned within the casing and has defined therethrough a first aperture in fluid communication with the atmosphere through the casing and a second aperture in fluid communication with the air bladder through the casing. Included within the housing are at least two switches and a diaphragm positioned between the switches. The housing is sealed so that when a threshold pressure is reached therein, at least one switch is triggered by deflection of the diaphragm to automatically deactivate the pump by de-energizing the motor. | 12-29-2011 |
Patent application number | Description | Published |
20160078560 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078561 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078562 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078563 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078564 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078565 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
20160078566 | ADAPTIVE EXPENSE PROCESSING AND MANAGEMENT - Methods and apparatus for adaptive expense processing and management include receiving and generating expense data objects, performing one or more expense processing and/or management procedures, adjusting/updating expense data from a first set to a second set for use in an autonomous expense procedure, and generating one or more additional or subsequent expense data objects based on the second set of expense data. For example, one or more account formation characteristics may be determined during an account formation procedure. Further, a merchant identity procedure may be performed. Additionally, the methods and apparatus may perform an expense category estimation procedure. The methods and apparatus may also determine a duplicate expense data object and perform an expense resolution procedure. | 03-17-2016 |
Patent application number | Description | Published |
20140039523 | METHOD AND APPARATUS FOR SKIN RESURFACING - Exemplary embodiments of method and apparatus are provided for resurfacing of skin that includes formation of a plurality of small holes, e.g., having widths less than about 1 mm or 0.5 mm, using a mechanical apparatus, thus avoiding generation of thermal damage as occurs with conventional laser resurfacing procedures and devices. The holes formed can be well-tolerated by the skin, and can exhibit shorter healing times and less swelling than conventional resurfacing procedures. The apparatus includes one or more needles adapted to remove a small portion of tissue when inserted into and withdrawn from the skin. The fractional surface coverage of the holes can be between about 0.1 and 0.7, or between about 0.2 and 0.5. The exemplary method and apparatus can produce cosmetic effects such as increases in collagen content, epidermal thickness, and dermal/epidermal junction undulations in the skin. | 02-06-2014 |
20140163582 | METHOD AND APPARATUS FOR DISCONTINUOUS DERMABRASION - Exemplary embodiments of method and apparatus are provided for resurfacing of skin that includes formation of a plurality of small holes, e.g., having widths less than about 1 mm or 0.5 mm. For example, such small holes can be produced using a mechanical apparatus that includes one or more abrading elements provided at the end of one or more rotating shafts, thus avoiding generation of thermal damage as occurs with conventional laser resurfacing procedures and devices. The holes thus formed can be well-tolerated by the skin, and may exhibit shorter healing times and less swelling than conventional resurfacing procedures. The fractional surface coverage of the holes can be between about 0.1 and 0.7, or between about 0.2 and 0.5. The method and apparatus can produce cosmetic improvements in the skin appearance by eliciting a healing response. | 06-12-2014 |
20140296741 | METHOD AND APPARATUS FOR SUBSURFACE TISSUE SAMPLING - Exemplary embodiments of method and apparatus are provided for removing a subsurface sample of a biological tissue while leaving the overlying tissue substantially undamaged. A hollow needle can be provided that includes an opening in the wall and a protruding cutting edge adjacent to the opening. A sliding sleeve can be provided over a portion of the needle. The needle and sleeve can be advanced into the tissue such that the cutting edge is deeper than the distal end of the sleeve. The needle may then be withdrawn while holding the sleeve stationary, such that a sample is severed by the cutting edge and directed into the hollow needle through the opening, until the cutting edge reaches the end of the sleeve. The sleeve and needle containing the sample can then be withdrawn from the tissue together. | 10-02-2014 |